Retraction

Micro-RNA-143 inhibits proliferation and promotes apoptosis of thymocytes by targeting CXCL13 in a myasthenia gravis mouse model

Retraction Details

Nature of Retraction:

Retraction

Additional Notes:

see also: https://pubpeer.com/publications/5574C78FCBD28657D80218EDE9A45A; see also: https://www.nsfc.gov.cn/publish/portal0/tab442/info85495.htm

Citations (5)

5
Total Citations
2
Post-Retraction
(40.0%)
2
Pre-Retraction
0
Same Day
Post-Retraction Citation Analysis
0 Within 30 days
1 Within 1 year
1 After 2+ years
852 Days since retraction (latest)
Heavy Metals Removal Using Carbon Based Nanocomposites
Unknown Authors
Unknown Journal
Published: Unknown
Transcriptome analysis reveals the clinical significance of CXCL13 in Pan-Gyn tumors
Yue Ding, Quan Zhou, Bo Ding et al. (5 authors)
Journal of Cancer Research and Clinical Oncology Open Access
Published: Mar 2024
1 citation
852 days after retraction
Role of the CXCL13/CXCR5 Axis in Autoimmune Diseases
Zijian Pan, Tong Zhu, Yanjun Liu et al. (4 authors)
Frontiers in Immunology Open Access
Published: Mar 2022
73 citations
116 days after retraction
Role of miRNAs in Normal and Myasthenia Gravis Thymus
Mélanie A. Cron, Émilie Guillochon, Linda L. Kusner et al. (4 authors)
Frontiers in Immunology Open Access
Published: Jun 2020
22 citations
516 days before retraction
<p>CircHIPK3 Promotes Clear Cell Renal Cell Carcinoma (ccRCC) Cells Proliferation and Metastasis via Altering of miR-508-3p/CXCL13 Signal</p>
Bin Han, E Shaolong, Lan Luan et al. (5 authors)
OncoTargets and Therapy Open Access
Published: Jun 2020
29 citations
525 days before retraction
Quick Stats
Total Citations: 9
Years Since Retraction: 4.0 years
Open Access: Yes
Last Checked: Jul 24, 2025
Related Papers
Angiotensin II-induced upregulation of AT(1) receptor expre…
American Journal of Physiology - Cell Physiology • 67 citations
Reprogramming glioblastoma multiforme cells into neurons by…
Journal of Experimental & Clinical Cancer Research: (CR) • 12 citations